Viewing Study NCT03769506


Ignite Creation Date: 2025-12-26 @ 5:20 PM
Ignite Modification Date: 2026-03-03 @ 4:02 PM
Study NCT ID: NCT03769506
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-16
First Post: 2018-12-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy
Sponsor: Rakuten Medical, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rakuten Medical View
None ASP-1929 View
None PIT View
None Photoimmunotherapy View
None HNC View
None HNSCC View
None Head and neck View
None EGFR View
None Cetuximab View
None Erbitux View
None RM-1929 View